The Real Problem With Withdrawing Avastin
January 19th, 2011
 by
Paul Howard
|
In late December, the Food and Drug Administration (FDA) revoked approval of the cancer drug Avastin for metastatic breast cancer. The decision set off a firestorm of reaction: the right condemned the denial of a potential life-saving drug for breast cancer patients, while the left cheered the withdrawal of an expensive drug that seemed to offer little... Read the rest of this entry »
